HomeBUSINESS
BUSINESS

Kyowa Kirin Gains Rights to NHE3 Inhibitor in Japan
(Nov.29.2017)

Kyowa Hakko Kirin said on November 28 that it has entered into a license agreement with Ardelyx for exclusive rights to develop and commercialize the US company’s NHE3 inhibitor tenapanor in Japan ...
(LOG IN FOR FULL STORY)

News Calendar